Phenylboronic Acid

Phenylboronic Acid

SCHEMBL2915212

C=CC(C)OC(N)=O.OB(O)c1ccccc1

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 2/20 0.42
CA4 P22748 1/20 0.42
CA6 P23280 1/20 0.42
CA5A P35218 1/20 0.42
CA7 P43166 1/20 0.42
CA14 Q9ULX7 1/20 0.42
CA5B Q9Y2D0 1/20 0.42
CA1 P00915 3/20 0.35
CA2 P00918 3/20 0.35
P4HB P07237 1/20 0.35
PCSK9 Q8NBP7 1/20 0.34
ORAI1 Q96D31 1/20 0.34
ORAI2 Q96SN7 1/20 0.34
ORAI3 Q9BRQ5 1/20 0.34
TRPV6 Q9H1D0 1/20 0.34
MGLL Q99685 2/20 0.34
HCAR2 Q8TDS4 1/20 0.33
TSHR P16473 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28693892 0.78
SCHEMBL59826 0.78
Phenylboronic Acid SCHEMBL1723445 0.75 CA4 (0.58) ENPP2CA4CA6CA5ACA7
Acrylic Acid SCHEMBL26099444 0.75 LMNA (0.42) HCAR2TSHR
Phenylboronic Acid SCHEMBL28704052 0.72 ENPP2 (0.67) ENPP2CA4CA6CA5ACA7
Phenylboronic Acid SCHEMBL6701482 0.72 ENPP2 (0.74) ENPP2CA4CA6CA5ACA7
Phenylboronic Acid SCHEMBL28944102 0.72 ENPP2 (0.74) ENPP2CA4CA6CA5ACA7
Phenylboronic Acid SCHEMBL28945198 0.70 CA4 (0.64) ENPP2CA4CA6CA5ACA7
SCHEMBL9330992 0.70 TSHR (0.53) CA7CA14CA1CA2TSHR
Phenylboronic Acid SCHEMBL28603700 0.70 ENPP2 (0.70) ENPP2CA4CA6CA5ACA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10765110-B2 Agent for preserving biological component Tabata, Yasuhiko (JP) 2020-09-08 US disclosed
US-20170311586-A1 AGENT FOR PRESERVING BIOLOGICAL COMPONENT, AND METHOD FOR RECOVERING BIOLOGICAL COMPONENT Tabata, Yasuhiko (JP) 2017-11-02 US disclosed
EP-3219787-A1 AGENT FOR PRESERVING BIOLOGICAL COMPONENT, AND METHOD FOR RECOVERING BIOLOGICAL COMPONENT Denka Company Limited (JP) 2017-09-20 EP disclosed
US-20110059176-A1 MATERIAL FOR PREVENTING TISSUE ADHESION AND MATERIAL FOR PREVENTING JOINT CONTRACTURE THE UNIVERSITY OF TOKYO (JP) 2011-03-10 US disclosed
EP-2226075-A1 MATERIAL FOR PREVENTING TISSUE ADHESION AND MATERIAL FOR PREVENTING JOINT CONTRACTURE The University of Tokyo (JP) 2010-09-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110059176-A1 MATERIAL FOR PREVENTING TISSUE ADHESION AND MATERIAL FOR PREVENTING JOINT CONTRACTURE PTK2, MUSK, TNNC1 ENPP2 2062/4885CA4 1998/4885CA6 629/4885
US-20170311586-A1 AGENT FOR PRESERVING BIOLOGICAL COMPONENT, AND METHOD FOR RECOVERING BIOLOGICAL COMPONENT CD44, HPSE, PLOD3 ENPP2 586/4885CA4 820/4885CA6 723/4885
US-10765110-B2 Agent for preserving biological component CD44, MUC1, PLOD3 ENPP2 538/4885CA4 907/4885CA6 911/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.